Xcout Intel
Peptilogics, Inc.
Peptilogics, Inc. is a biotechnology company founded in 2013 and headquartered in Pittsburgh, Pennsylvania. The company utilizes advanced computational and biological approaches to discover and develop novel peptide therapeutics.
Subscribe to see Peptilogics, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Peptilogics, Inc. at a glance
Peptilogics, Inc. is a biotech company headquartered in United States. It has raised at least $40.9M across the 4 funding rounds on record. Its most recent funding round raised $35.8M in December 2020. Xcout recorded 3 job postings from Peptilogics, Inc. in the last 90 days.
Peptilogics, Inc. funding rounds
At least $40.9M raised across the 4 rounds on record. Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| SEC Form D filing | $35.8M | — | |
| SEC Form D filing | $4M | — | |
| SEC Form D filing | $753,999 | — | |
| Seed | $417,000 | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Hiring at Peptilogics, Inc.
Xcout recorded 3 job postings from Peptilogics, Inc. in the last 90 days, from a hiring record Xcout has kept since July 2026.
The weekly hiring trend, the roles and locations behind it — see Peptilogics, Inc.'s hiring signals →
Tech stack
Peptilogics, Inc. competitors
A few of Peptilogics, Inc.'s closest competitors — see the full list of competitors and alternatives →
Meddenovo Drug Design is a Lyon, France-based biotechnology company operating at the intersection of AI and life sciences to build advanced computational technologies for peptide drug discovery.
Biolojic Design is an Israeli biotechnology company that uses computational modeling and artificial intelligence to design and engineer antibodies and other therapeutic proteins. It develops drug candidates and collaborates with pharmaceutical and biotechnology companies seeking novel biologic medicines.
Protagonist Therapeutics is a clinical-stage biopharmaceutical company headquartered at the Pacific Research Center in Newark, California, focused on peptide drug discovery.
Parabilis Medicines is a biopharmaceutical company that develops ultra-tunable peptide therapeutics utilizing its proprietary Helicon platform. The company focuses on creating novel medicines to target historically undruggable conditions, primarily addressing cancer and other serious diseases with critical medical needs.
Undaunted Bio, Inc. is an AI-driven drug repurposing company headquartered in Pittsburgh, United States, focused on treatments for neuropathic pain.
Launched in 2022 and headquartered in Seattle, Washington, Vilya is an AI peptide company co-founded by scientists from the Institute of Protein Design. The company uses artificial intelligence and synthetic biology to design novel macrocycle therapeutics inspired by nature.
Get Peptilogics, Inc.'s news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Peptilogics, Inc. in Xcout Intel
- 4 funding rounds with the investors in each, and who they co-invest with
- Weekly hiring history and the mix of roles behind it
- The full competitor set, tracking, exports and API access